{"nct_id":"NCT04460729","title":"A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases","status":"WITHDRAWN","status_verified_date":"2020-11","start_date":"2020-11-11","start_date_type":"ESTIMATED","primary_completion_date":"2023-11-17","primary_completion_date_type":"ESTIMATED","completion_date":"2023-11-17","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVS"]}